Literature DB >> 6288533

[Capillary embolization. Part II. Occlusion of the entire arterial system of experimentally induced renal tumors ].

G Richter, R Rohrbach, G W Kauffmann, J Rassweiler.   

Abstract

221 renal rat tumors (induced by Dimethylnitrosamine) are embolized by gelfoam powder, IBC/Lipiodol and Ethibloc/Glucose. The effect of those embolization media is compared to ligation and glucose perfusion. Recurrencies and rate of surviving tumor tissue are dependent on the stage of the neoplasm, sufficient capillary propagation of the medium, and exact volume-dependent embolization. It could be proven that large areas of renal rat tumors are equally supplied by the main artery and parasitary collaterals. Only homogeneous distribution and complete downstream propagation of the embolization medium from the main artery to the capillaries will achieve breakdown of this parasitary supply. Glucose governed Ethibloc embolization achieves in 80% of tumors with a 6 fold renal volume and in 50% of larger tumors complete necrosis. It has the lowest complication rate of all tested materials.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6288533     DOI: 10.1055/s-2008-1056836

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  4 in total

1.  Homologous controlled-viscosity fibrin for endovascular embolization. Part II: catheterization technique, animal experiments.

Authors:  B Richling
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

2.  [Palliative therapy of primary liver tumors].

Authors:  C Kelm; K Henneking; T Zimmermann; M Vollerthun; W Padberg
Journal:  Langenbecks Arch Chir       Date:  1993

3.  Prolonged survival following palliative renal tumor embolization by capillary occlusion.

Authors:  G W Kauffmann; G M Richter; R Rohrbach; W Wenz
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Jan-Feb       Impact factor: 2.740

4.  Embolization with "Ethibloc" of vascular tumors and arteriovenous malformations in the head and neck.

Authors:  D Kühne; K Helmke
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.